About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Tools for Lasting Lifestyle Changes | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03807323

Tools for Lasting Lifestyle Changes

Pilot and feasibility study; a complex intervention focusing on lifestyle change to increase physical activity and reduce cardiovascular disease (CVD) risk among high risk individuals.

Lead sponsor: University of Tromso•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Tromso

Collaborators

University Hospital of North Norway

Interdisciplinary, mixed-method, prospective and single-arm exploratory study aimed to explore study feasibility, responsiveness, participants adherence and adverse events among the participants before deciding to proceed to full-scale evaluation. Enrollment of max. 20 obese people (BMI\>30) with sedentary lifestyle and increased CVD-risk (NORRISK2).. Participants general health status including cardiopulmonary fitness will be assessed both before and after the intervention (blood pressure, ECG, spirometry, treadmill tests VO2max, blood tests, body composition by Dual-energy X-ray absorptiometry (DEXA) measurements) Participants´ functional capacity assessed by several range of motion tests. Participants nutritional and psychological status assessed by validated questionnaires. Several blood-tests and ECG will be recorded at three months. Daily activity level during and six months after the intervention period monitored by Polar M430 pulse watch. The participants will be interviewed with focus on their prior health, activity habits and intervention experiences at three months and six months after end of the intervention. Two focus-group interviews at end of intervention.

Age

55 - 75 years

Sex

All

Healthy Volunteers

No

Inclusion Criteria

•1. Age 55-74 years
•2. BMI\> 30
•3. Moderate elevated NORRISK 2 score
•4. Motivation for lifestyle change
•5. Has agreed to attend and participate in a student study during the study period

Exclusion Criteria

•5.EKG changes that show severe rhythm disturbance, unstable angina or heart attack:

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.

NCT06903442 · Cardiovascular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 16, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment16

Start dateSep 2017

Last updatedJan 16, 2019

Condition

Cardiovascular Diseases Lifestyle Risk Reduction

Locations shown

UiT the Arctic University of Norway

Tromsø

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 16, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions